Survivorship Care for Ovarian Cancer
(POSTCARE-O Trial)
Trial Summary
What is the purpose of this trial?
This trial tests the POSTCare-O process, a telehealth support program for women who have completed initial treatment for Stage 2-4 ovarian cancer. The program offers ongoing support and guidance from healthcare professionals to help manage health and improve quality of life.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, it mentions that continued maintenance therapy is okay, so you might be able to stay on some treatments.
What data supports the effectiveness of the POSTCare Survivorship transition process treatment for ovarian cancer?
The POSTCare intervention, which is used for breast cancer survivors, involves a single coaching session that helps patients manage their care after treatment. This approach, based on the Chronic Care Model and using motivational interviewing, has shown positive effects on patient outcomes and care coordination, suggesting it may also benefit ovarian cancer survivors.12345
Is the POSTCare Survivorship transition process safe for humans?
How is the POSTCare Survivorship transition process treatment different from other treatments for ovarian cancer?
The POSTCare Survivorship transition process is unique because it focuses on helping ovarian cancer survivors transition from specialized cancer care to self-management and primary care. It uses motivational interviewing techniques to engage patients, which is different from traditional treatments that primarily focus on medical interventions.12356
Research Team
Elizabeth Kvale, MD,MPH
Principal Investigator
Baylor College of Medicine
Eligibility Criteria
This trial is for women who have completed initial treatment for stage 2-4 ovarian cancer within the last 6 months. They must have undergone surgery, chemotherapy, biologics, or maintenance therapy and be able to consent in English or Spanish. Women admitted to hospice after ovary cancer treatment cannot participate.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive survivorship care using the POSTCare-O process or usual care
Follow-up
Participants are monitored for quality of life, fear of recurrence, and symptom burden
Treatment Details
Interventions
- POSTCare Survivorship transition process (Behavioral)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Baylor College of Medicine
Lead Sponsor
University of Texas Southwestern Medical Center
Collaborator
Cancer Prevention Research Institute of Texas
Collaborator
The University of Texas Health Science Center, Houston
Collaborator
University of Texas at Austin
Collaborator
University of Texas - Austin
Collaborator
UT Houston School of Public Health
Collaborator
UT Southwest
Collaborator